CB Scientific Inc
Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Card… Read more
CB Scientific Inc (CBSC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.067x
Based on the latest financial reports, CB Scientific Inc (CBSC) has a cash flow conversion efficiency ratio of 0.067x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-141.06K) by net assets ($-2.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CB Scientific Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how CB Scientific Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CB Scientific Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CB Scientific Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Draw Distance SA
WAR:DDI
|
-0.143x |
|
ICT Zone Asia Berhad
KLSE:0358
|
N/A |
|
Fidelity China Special Situations PLC
LSE:FCSS
|
0.023x |
|
Symmetry Group Ltd.
KAR:SYM
|
N/A |
|
Max’s Group Inc
PSE:MAXS
|
0.075x |
|
Seafront Resources Corp
PSE:SPM
|
0.000x |
|
El Arabia Engineering Industries
EGX:EEII
|
N/A |
|
Keepers Holdings Inc
PSE:KEEPR
|
-0.098x |
Annual Cash Flow Conversion Efficiency for CB Scientific Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of CB Scientific Inc from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-03-31 | $-642.81K | $-1.25 Million | 1.937x | -38.49% |
| 2023-03-31 | $-376.86K | $-1.19 Million | 3.150x | +296.01% |
| 2022-03-31 | $489.13K | $-786.03K | -1.607x | -146.05% |
| 2021-03-31 | $-189.88K | $-662.59K | 3.490x | +905.15% |
| 2020-03-31 | $-1.97 Million | $-682.71K | 0.347x | +229.63% |
| 2019-03-31 | $-1.03 Million | $-108.69K | 0.105x | -83.37% |
| 2018-03-31 | $-1.21 Million | $-768.73K | 0.633x | +425.09% |
| 2017-03-31 | $-518.12K | $-62.49K | 0.121x | +2497.47% |
| 2016-03-31 | $-342.67K | $1.72K | -0.005x | -- |